Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Cord Blood Lands $50 Million from Golden Meditech

publication date: Sep 18, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Cord Blood Corp. announced that its corporate parent, Golden Meditech Holdings, would invest another $50 million in China Cord Blood, allowing it to expand its business – perhaps beyond China. Golden Meditech already owns 42% of CCBC. The new investment is a convertible bond that can be converted into another 15.5% of the company. CCBC seems to already have a lot of cash.  More details....

Stock Symbols: (NYSE: CO) (HK: 801; TW: 910801)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners